Research Article
Importance of Altered Gene Expression of Metalloproteinases 2, 9, and 16 in Acute Myeloid Leukemia: Preliminary Study
Table 1
Clinical characteristics of patients with acute myeloid leukemia.
| | Clinical feature | Types of cases | Number of cases (N) | Average age (years) |
| | Gender | Men | 25 | 57 (SD 14, 5) | | Women | 31 | 60 (SD 15, 02) |
| | AML morphological subtype | AML1 | 3 (2 W; 1 M) | 59 (SD 13, 10) | | AML2 | 7 (5 W; 2 M) | 61 (SD 12, 51) | | AML3 | 1 (1 M) | 26 (SD 0, 00) | | AML4 | 6 (3 W; 3 M) | 59 (SD 22, 94) | | AML5 | 3 (1 W; 2 M) | 39 (SD 16, 21) | | AML6 | 1 (1 M) | 57 (SD 0, 00) | | AML7 | 0 | — | | Indefinite | 35 (20 W; 15 M) | 61 (SD 11, 51) |
| | Karyotype | Normal | 10 (3 W; 7 M) | 55 (SD 9, 86) | | Abnormal | 17 (10 W; 7 M) | 56 (SD 16, 98) | | Indefinite | 29 (18 W; 11 M) | 63 (SD 10, 72) |
| | Result of induction treatment | Complete remission | 14 (6 W; 8 M) | 48 (SD 14, 47) | | No remission | 16 (7 W; 9 M) | 63 (SD 9, 59) | | Indefinite | 26 (18 W; 8 M) | 64 (SD 10, 87) |
|
|
W: women; M: men.
|
